Duration of antibiotic prophylaxis for cardiac surgery: Prospective observational study

Journal of Infection

Volumn 58, Issue 4, 2009, Pages 291-298

  Paul, Mical ^a   Porat, Eyal ^a   Raz, Aeyal ^a   Madar, Hefziba ^a   Fein, Shai ^a   Bishara, Jihad ^a   Biderman, Phillippe ^a   Medalion, Benjamin ^a   Sharoni, Erez ^a   Eidelman, Leonid ^a   Leibovici, Leonard ^a   Rubinovitch, Bina ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Antibiotic prophylaxis; Cardiac surgery; Surgical site infection

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFONICID; CLINDAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; AORTA SURGERY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART SURGERY; HEART VALVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PEROPERATIVE CARE; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; RISK FACTOR; SINGLE DRUG DOSE; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT DURATION;

AGED; ANALYSIS OF VARIANCE; ANTIBIOTIC PROPHYLAXIS; CARDIAC SURGICAL PROCEDURES; CEFAZOLIN; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 63349088864     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.02.008     Document Type: Article

References (19)

1. Edwards F.H., Engelman R.M., Houck P., Shahian D.M., and Bridges C.R. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg 81 (2006) 397-404
2. Bratzler D.W., and Houck P.M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38 (2004) 1706-1715
3. Engelman R., Shahian D., Shemin R., Guy T.S., Bratzler D., Edwards F., et al. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice. Ann Thorac Surg 83 (2007) 1569-1576
4. Paul M., Raz A., Leibovici L., Madar H., Holinger R., and Rubinovitch B. Sternal wound infection after coronary artery bypass graft surgery: validation of existing risk scores. J Thorac Cardiovasc Surg 133 (2007) 397-403
5. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
6. Roques F., Michel P., Goldstone A.R., and Nashef S.A. The logistic EuroSCORE. Eur Heart J 24 (2003) 881-882
7. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
8. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
9. Kreter B., and Woods M. Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg 104 (1992) 590-599
10. Kriaras I., Michalopoulos A., Turina M., and Geroulanos S. Evolution of antimicrobial prophylaxis in cardiovascular surgery. Eur J Cardiothorac Surg 18 (2000) 440-446
11. Tamayo E., Gualis J., Florez S., Castrodeza J., Bouza J.M., and Alvarez F.J. Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery. J Thorac Cardiovasc Surg 136 (2008) 1522-1527
12. Carignan A., Allard C., Pepin J., Cossette B., Nault V., and Valiquette L. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis (2008)
13. Harbarth S., Samore M.H., and Carmeli Y. Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. J Hosp Infect 48 (2001) 93-97
14. Kreisel D., Savel T.G., Silver A.L., and Cunningham J.D. Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 130 (1995) 989-993
15. Jonkers D., Swennen J., London N., Driessen C., and Stobberingh E. Influence of cefazolin prophylaxis and hospitalization on the prevalence of antibiotic-resistant bacteria in the faecal flora. J Antimicrob Chemother 49 (2002) 567-571
16. Kernodle D.S., Barg N.L., and Kaiser A.B. Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother 32 (1988) 202-208
17. Harbarth S., Samore M.H., Lichtenberg D., and Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 101 (2000) 2916-2921
18. Gandhi G.Y., Nuttall G.A., Abel M.D., Mullany C.J., Schaff H.V., O'Brien P.C., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 146 (2007) 233-243
19. Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461